Zeynab Najafova was born in Baku, Azerbaijan in 1986. After obtaining her diploma in 2009 from the Medical Biology Faculty of Azerbaijan Medical University, she moved to Germany where she completed her Masters of Science in Molecular Medicine from the Georg-August-University Göttingen in 2012. During her doctoral work in Hamburg and Göttingen, Zeynab elucidated epigenetic regulatory mechanisms controlling osteoblastic differentiation. She completed her Ph.D. with highest honors (summa cum laude) in 2016. In 2018 Zeynab was awarded a Dorothea-Schlözer fellowship from the University of Göttingen to promote her independent research dedicated to characterization of enhancer RNAs as diagnostic and prognostic markers for molecular stratification of patients with pancreatic ductal adenocarcinoma. In 2020 Zeynab joined the Research Informatics Group at Evotec International GmbH to work on clinically relevant topics involving large patient cohorts. In May 2022 she assumed her current position as a group leader at the Robert Bosch Center for Tumor Diseases.
Relevant own publications
See more on ORCID